Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
BIOQUBE VENTURES from Hasselt, company number BE0738714089, closed financial year 2025 with a result of € -31,934 after tax. For that financial year BIOQUBE VENTURES recorded a gross margin of € -26,324 and equity of € 33,323. Compared with financial year 2024, the result moved from € -17,376 to € -31,934. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 33,323
▼ 49% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -31,934
▼ 84 % more loss than in 2024
Profit after tax over the fiscal year.
€ 165,947
▲ € 143,477 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -28,177.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 8,540
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 341,848
▼ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 103,493 | € 312,788 | € 28,365 | € -26,324 | ▼ € 54,689 |
| Profit after taxes | € 58,026 | € 179,627 | € -17,376 | € -31,934 | ▼ € 14,559 |
| Equity | € 146,113 | € 325,740 | € 65,257 | € 33,323 | ▼ 49% |
| Total debts | € 222,631 | € 177,056 | € 448,473 | € 347,187 | ▼ 23% |
| Cash | € 188,530 | € 103,225 | € 22,470 | € 165,947 | ▲ € 143,477 |
| Retained profit | € 84,613 | € 264,240 | € 3,757 | € -28,177 | ▼ € 31,934 |
| Bank debt | € 37,747 | € 21,155 | € 0 | € 0 | |
| Balance sheet total | € 368,744 | € 502,796 | € 513,731 | € 380,510 | ▼ 26% |
| Employees (FTE) | 0.2 | 0.9 | 0 | 0 |
Key figures of BIOQUBE VENTURES, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOQUBE VENTURES?
What happened at BIOQUBE VENTURES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 31,934. Source: NBB ↗
- New establishment in Hasselt. KBO
- New establishment in Hasselt. KBO
- Start of the company according to the CBE. KBO
- DEBORA DUMONT MANAGEMENT COMPANY CommV became a director. NBB
- NICO VANDERVELPEN MANAGEMENT COMPANY BV became a director. NBB
- R&S Consulting BV became a director. NBB
In short
From € 58,026 profit in 2021 to € 31,934 loss in 2025.
Paid € 85,188 in corporate taxes since 2021.
Best year ever: 2022, with € 179,627 profit.
A new publication or filing at BIOQUBE VENTURES? We notify you, reason included.
Follow BIOQUBE VENTURESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of R&S Consulting, DEBORA DUMONT MANAGEMENT COMPANY, NICO VANDERVELPEN MANAGEMENT COMPANY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BIOQUBE VENTURESBehind BIOQUBE VENTURES are DEBORA DUMONT MANAGEMENT COMPANY CommV, NICO VANDERVELPEN MANAGEMENT COMPANY BV and R&S Consulting BV. The shares are held by R&S Consulting (33.3%), DEBORA DUMONT MANAGEMENT COMPANY (33%) and NICO VANDERVELPEN MANAGEMENT COMPANY (33%).
Directors
According to the 2025 annual accounts
DEBORA DUMONT MANAGEMENT COMPANY CommV
Director · represented by Dumont Debora
Also active at: BQV Partners, SPICA THERAPEUTICS
since 2019
NICO VANDERVELPEN MANAGEMENT COMPANY BV
Director · represented by Nico Vandervelpen
Also active at: BQV Partners
since 2019
since 2019
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Uilstraat 30
3500 Hasselt
Thonissenlaan 51
3500 Hasselt
Active since 21 April 2026
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0738.714.089
- VAT number
- BE 0738.714.089
- Registered office
- Uilstraat 30, 3500 Hasselt
- Names & denominations
- BIOQUBE VENTURES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 December 2019
- Peppol
- Active · Active since 25 Sept 2026
- Activities · NACE
Vermogensbeheer